Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-013812
Filing Date
2021-03-29
Accepted
2021-03-29 16:35:26
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6837
  Complete submission text file 0000899243-21-013812.txt   8354
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
OMENN GILBERT S (Reporting) CIK: 0001184227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 21782136